Search research articles
Contact Us
Filters
Showing results (221-230 of 278) with videos related to
Page
of 28
Sort By:
Haematologica
|
March 1, 2006
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points
Angela Dispenzieri, Morie A Gertz, Martha Q Lacy, et al.
Angewandte Chemie (International Ed. in English)
|
September 20, 2021
Facet-Selective Deposition of Ultrathin Al<sub>2</sub> O<sub>3</sub> on Copper Nanocrystals for Highly Stable CO<sub>2</sub> Electroreduction to Ethylene
Hui Li, Peiping Yu, Renbo Lei, et al.
Gastro Hep Advances
|
April 21, 2025
Clinical Phenotypes May be Able to Identify Populations With Nonalcoholic Fatty Liver-Spectrum Disease
Bridget M Geyer, Feier Chang, Peng Wu, et al.
Leukemia
|
April 12, 2003
Thalidomide as initial therapy for early-stage myeloma
S V Rajkumar, M A Gertz, M Q Lacy, et al.
Leukemia
|
August 2, 2001
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia
A Tefferi, C Y Li, C B Reeder, et al.
Diabetologia
|
August 4, 2017
Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Manuela Battaglia, Mark S Anderson, Jane H Buckner, et al.
Diabetologia
|
September 27, 2017
Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Manuela Battaglia, Mark S Anderson, Jane H Buckner, et al.
Critical Care Medicine
|
December 11, 2012
Innate immune function and mortality in critically ill children with influenza: a multicenter study
Mark W Hall, Susan M Geyer, Chao-Yu Guo, et al.
Cancer
|
June 22, 2010
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study
Susan M Geyer, Lindsay M Morton, Thomas M Habermann, et al.
Leukemia
|
June 22, 2007
A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia
R A Mesa, J K Camoriano, S M Geyer, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 278) with videos related to
Sort By:
Page
of 28
Haematologica
|
March 1, 2006
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points
Angela Dispenzieri, Morie A Gertz, Martha Q Lacy, et al.
Angewandte Chemie (International Ed. in English)
|
September 20, 2021
Facet-Selective Deposition of Ultrathin Al<sub>2</sub> O<sub>3</sub> on Copper Nanocrystals for Highly Stable CO<sub>2</sub> Electroreduction to Ethylene
Hui Li, Peiping Yu, Renbo Lei, et al.
Gastro Hep Advances
|
April 21, 2025
Clinical Phenotypes May be Able to Identify Populations With Nonalcoholic Fatty Liver-Spectrum Disease
Bridget M Geyer, Feier Chang, Peng Wu, et al.
Leukemia
|
April 12, 2003
Thalidomide as initial therapy for early-stage myeloma
S V Rajkumar, M A Gertz, M Q Lacy, et al.
Leukemia
|
August 2, 2001
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia
A Tefferi, C Y Li, C B Reeder, et al.
Diabetologia
|
August 4, 2017
Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Manuela Battaglia, Mark S Anderson, Jane H Buckner, et al.
Diabetologia
|
September 27, 2017
Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Manuela Battaglia, Mark S Anderson, Jane H Buckner, et al.
Critical Care Medicine
|
December 11, 2012
Innate immune function and mortality in critically ill children with influenza: a multicenter study
Mark W Hall, Susan M Geyer, Chao-Yu Guo, et al.
Cancer
|
June 22, 2010
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study
Susan M Geyer, Lindsay M Morton, Thomas M Habermann, et al.
Leukemia
|
June 22, 2007
A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia
R A Mesa, J K Camoriano, S M Geyer, et al.
Page
of 28